CHD4 Antibody CSB-PA595285
Classification:
Polyclonal Antibody
Alternative names:
ATP dependent helicase CHD4 antibody; ATP-dependent helicase CHD4 antibody; CHD 4 antibody; CHD-4 antibody; CHD4 antibody; CHD4_HUMAN antibody; Chromodomain helicase DNA binding protein 4 antibody; Chromodomain-helicase-DNA-binding protein 4 antibody; Mi 2 autoantigen 218 kDa protein antibody; Mi 2b antibody; Mi-2 autoantigen 218 kDa protein antibody; Mi2 beta antibody; Mi2-beta antibody
Research area:
Immunology
Species reactivity:
Human, Mouse
Antigen species:
Homo sapiens (Human)
Host species:
Rabbit
Clonality:
Polyclonal
Isotype:
IgG
Antigen:
Synthesized peptide derived from internal of Human CHD4.
Target name:
CHD4
Purification method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Buffer:
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Conjugate:
Non-conjugated
Form:
liquid
Tested applications:
ELISA, IHC, IF
Storage:
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
Fine Biotech is an ISO9001:2008 Certified Company,offers a full line of quality research kits,which include ELISA Kits,related ELISA assistant reagents and more high quality antibodies, recombinant proteins. Fine Biotech technical support are delicated to providing with professional and friendly assistance for our customers. Strict and multiple quality control ensure that our products continue to successfully supply for the international market. Moreover, we strive to continuously improve the customer experience through comprehensive technical support. High quality,rapid turnaround and personal support for all FineTest services are guaranteed. Should you have any problems,or any ideas on ways that we can improve our service,please feel free to call upon us.Thank you for your interest in FineTest products and we look forward to supplying you in the near future.